ÂÜÀòÂÒÂ×

David Weng is a seasoned oncology and hematology expert currently serving as a Partner at Maryland Oncology Hematology since October 2020. Prior to this role, David held various positions at Luminis Health from February 2014 to October 2020, where responsibilities included medical staff work in medical oncology and hematology. David's extensive experience encompasses leadership roles at TetraLogic Pharmaceuticals as Senior Vice President, Chief Medical Officer, and Vice President of Clinical Oncology from August 2009 to February 2014, as well as a role as Director at MedImmune from August 2006 to August 2009. Early career experiences include serving as Staff at Cleveland Clinic and completing an oncology fellowship at the National Cancer Institute. David completed medical residency at Johns Hopkins Hospital and holds an MD and Ph.D. in Biochemistry from The Johns Hopkins University School of Medicine, as well as an A.B. in Biochemistry from Harvard University.